For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $64.22 in the prior trading day, Dolby Laboratories Inc (NYSE: DLB) closed at $63.53, down -1.07%. In other words, the price has decreased by -$1.07 from its previous closing price. On the day, 0.69 million shares were traded. DLB stock price reached its highest trading level at $64.47 during the session, while it also had its lowest trading level at $63.25.
Ratios:
Our goal is to gain a better understanding of DLB by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.64 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.92. For the most recent quarter (mrq), Quick Ratio is recorded 3.10 and its Current Ratio is at 3.17. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In the most recent recommendation for this company, Robert W. Baird on September 05, 2025, initiated with a Neutral rating and assigned the stock a target price of $74.
Barrington Research Upgraded its Mkt Perform to Outperform on June 03, 2024, while the target price for the stock was maintained at $100.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 16 ’25 when YEAMAN KEVIN J sold 26,766 shares for $66.74 per share. The transaction valued at 1,786,310 led to the insider holds 105,128 shares of the business.
YEAMAN KEVIN J sold 6,751 shares of DLB for $453,929 on Dec 17 ’25. The President and CEO now owns 98,377 shares after completing the transaction at $67.24 per share. On Dec 16 ’25, another insider, SHERMAN MARK ANDREW, who serves as the EVP, Gen. Counsel & Secretary of the company, sold 9,109 shares for $66.73 each. As a result, the insider received 607,849 and left with 73,054 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DLB now has a Market Capitalization of 6067488768 and an Enterprise Value of 5413160448. As of this moment, Dolby’s Price-to-Earnings (P/E) ratio for their current fiscal year is 24.20, and their Forward P/E ratio for the next fiscal year is 14.09. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.46. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.50 while its Price-to-Book (P/B) ratio in mrq is 2.31. Its current Enterprise Value per Revenue stands at 4.012 whereas that against EBITDA is 14.718.
Stock Price History:
The Beta on a monthly basis for DLB is 0.88, which has changed by -0.18676394 over the last 52 weeks, in comparison to a change of 0.14778805 over the same period for the S&P500. Over the past 52 weeks, DLB has reached a high of $89.66, while it has fallen to a 52-week low of $64.02. The 50-Day Moving Average of the stock is -4.11%, while the 200-Day Moving Average is calculated to be -12.01%.
Shares Statistics:
The stock has traded on average 577.19K shares per day over the past 3-months and 632810 shares per day over the last 10 days, according to various share statistics. A total of 60.80M shares are outstanding, with a floating share count of 59.99M. Insiders hold about 37.19% of the company’s shares, while institutions hold 61.16% stake in the company. Shares short for DLB as of 1765756800 were 2886456 with a Short Ratio of 5.00, compared to 1763078400 on 2651832. Therefore, it implies a Short% of Shares Outstanding of 2886456 and a Short% of Float of 6.36.
Dividends & Splits
In the trailing 12 months, DLB’s forward annual dividend rate was 1.35, compared to 1.35 this year. Against a Trailing Annual Dividend Yield of 0.021021489. The stock’s 5-year Average Dividend Yield is 1.36.
Earnings Estimates
Current recommendations for the stock of the company come from 3.0 analysts. The consensus estimate for the next quarter is $1.36, with high estimates of $1.42 and low estimates of $1.31.
Analysts are recommending an EPS of between $4.36 and $4.2 for the fiscal current year, implying an average EPS of $4.26. EPS for the following year is $4.6, with 1.0 analysts recommending between $4.6 and $4.6.
Revenue Estimates
5 analysts predict $341.26M in revenue for. The current quarter. It ranges from a high estimate of $378M to a low estimate of $330.7M. As of. The current estimate, Dolby Laboratories Inc’s year-ago sales were $357MFor the next quarter, 5 analysts are estimating revenue of $383.15M. There is a high estimate of $399M for the next quarter, whereas the lowest estimate is $370.23M.
A total of 5 analysts have provided revenue estimates for DLB’s current fiscal year. The highest revenue estimate was $1.46B, while the lowest revenue estimate was $1.4B, resulting in an average revenue estimate of $1.41B. In the same quarter a year ago, actual revenue was $1.35BBased on 3 analysts’ estimates, the company’s revenue will be $1.46B in the next fiscal year. The high estimate is $1.48B and the low estimate is $1.44B.
